ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos2.12 B2.3 B2.08 B2.04 B2.23 B8.65 BInvestigación y desarrollo358 M405 M407 M410 M401 M1.62 BBeneficio operativo581 M837 M1.11 B1.14 B1.8 B4.89 BTotal de ingresos no operativos-53 M-73 M-97 M-106 M508 M232 MGastos por intereses, netos de intereses capitalizados104 M137 M159 M157 M129 M582 MIngresos no operativos, una vez deducidos los gastos por intereses-157 M-210 M-256 M-263 M379 M-350 MIngresos/gastos extraordinarios——————Beneficio antes de impuestos528 M764 M1.02 B1.03 B1.71 B4.51 BParticipación en los beneficios——————Impuestos-18 M110 M132 M170 M856 M1.27 BParticipación minoritaria——————Otros ingresos/gastos después de impuestos——————Beneficio neto antes de actividades interrumpidas546 M654 M884 M859 M849 M3.25 BOperaciones suspendidas——————Beneficio neto546 M654 M884 M859 M849 M3.25 BAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas546 M654 M884 M859 M849 M3.25 BBeneficio básico por acción1.431.712.322.252.218.49Beneficio por acción diluido1.411.692.292.222.28.4Número medio de acciones ordinarias381 M381.7 M382.2 M382.4 M382.2 M1.53 BAcciones diluidas385.6 M386.4 M386.4 M386.7 M386.5 M1.55 BEBITDA927 M1.2 B1.5 B1.54 B2.22 B6.46 BEBIT581 M837 M1.11 B1.14 B1.8 B4.89 BCosto de los ingresos2.26 B2.12 B2.18 B2.21 B2.54 B9.05 BOtros costes de producción——————Amortización y depreciación (flujo de caja)346 M361 M389 M404 M416 M1.57 B
Stryker Corporation
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000.